Sharanpreet Lall

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Accumulation of copy number alterations and clinical progression across advanced prostate cancer”.

Accumulation of copy number alterations and clinical progression across advanced prostate cancer

Genome Medicine(2022)10.1186/s13073-022-01080-4

N/A

0.889DataRank · unranked

30 citations

Stefanie Friedrich, Chris Brawley, Larissa Mendes, Marina Parry, Adnan Ali +28 more

External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol

The Lancet Digital Health(2025)10.1016/j.landig.2025.100885

N/A

0.573DataRank · unranked

17 citations

Larissa Mendes, Vinnie Y.T. Liu, Emily Grist, Songwan Joun, Rikiya Yamashita +35 more

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

Cell(2025)10.1016/j.cell.2025.07.042

N/A

0DataRank · unranked

24 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, James A. Proudfoot +42 more

Transcriptome classification of PTEN inactivation to predict survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for metastatic prostate cancer (PC): An ancillary study of the STAMPEDE trials.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5003

N/A

0DataRank · unranked

2 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, J. Proudfoot +15 more